跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 28,360 条关于
“Lennox–Gastaut syndrome”
全部
28,360
临床试验
25,233
药物
248
机构
15
资讯
2,864
去年
Comprehensive Clinical Trials Review Reveals Global Lennox-Gastaut Syndrome Research Landscape
去年
NHS Approves Fenfluramine for Children with Lennox-Gastaut Syndrome, Offering New Hope for Severe Epilepsy Treatment
去年
Fenfluramine Shows Sustained Safety Profile in Lennox-Gastaut Syndrome Treatment
去年
Soticlestat Fails to Meet Primary Endpoints in Phase III Trials for Dravet and Lennox-Gastaut Syndromes
去年
UCB Presents Comprehensive Epilepsy Research Portfolio at International Epilepsy Congress 2025
去年
Lundbeck Presents Bexicaserin Data for Developmental and Epileptic Encephalopathies at AES Annual Meeting
去年
Takeda Discontinues Soticlestat Development After Failed Phase III Epilepsy Trials
去年
UCB Pharma Eyes Further Expansion in South Korea Following Recent Drug Approvals
去年
UCB's Fenfluramine Achieves Positive Phase 3 Results in Ultra-Rare CDKL5 Deficiency Disorder
去年
Lundbeck's Bexicaserin Shows Sustained 59% Seizure Reduction in Rare Epilepsy Extension Study
第 1 页,共 287 页
上一页
下一页